Adam D. Talenfeld

Papers

Total Citations

H-Index

About

Adam D. Talenfeld is a clinician-researcher whose work centers on nephron-sparing oncologic interventions, particularly laparoscopic renal cryoablation. His most-cited paper, published in 2014, addresses a critical shift in urologic oncology: the move away from radical nephrectomy toward minimally invasive, kidney-preserving techniques. Talenfeld’s research underscores how radical nephrectomy can compromise renal function, leading to heightened risks of cardiovascular events and mortality—a concern that aligns with evolving American Urological Association (AUA) guidelines. By demonstrating the efficacy and safety of laparoscopic cryoablation for renal masses, he has contributed to a paradigm that prioritizes organ preservation without sacrificing oncologic control. Though his citation count (8 for this key paper) reflects a focused, early-stage impact, his work resonates within a community increasingly dedicated to reducing the long-term systemic consequences of cancer surgery. Talenfeld’s contributions are particularly valuable for trainees and practitioners navigating the balance between aggressive cancer treatment and renal function preservation, offering a data-driven rationale for adopting nephron-sparing approaches in appropriate candidates.